zoledronic acid has been researched along with Vitamin D Deficiency in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Sözel, H; Yilmaz, F | 1 |
| Jaiswal, S; Noriega Aldave, AP | 1 |
| Body, JJ; Bone, HG; Bracco, OL; Braun, A; Damião, R; de Boer, RH; Fizazi, K; Henry, DH; Ibrahim, T; Kostenuik, PJ; Lipton, A; Saad, F; Shaywitz, AJ; Shore, N; Stopeck, A; Takano, T; Van Poznak, C; Wang, H | 1 |
| Epperla, N; Pathak, R | 1 |
| Kannan, S; Mahadevan, S; Sathya, A; Sriram, U | 1 |
| Adams, JS; Christensen, R; Chung, EM; Felsenfeld, AL; Garrett, N; Hokugo, A; Nishimura, I; Sayre, JW; Sung, EC | 1 |
| Breen, TL; Shane, E | 1 |
7 other study(ies) available for zoledronic acid and Vitamin D Deficiency
| Article | Year |
|---|---|
Symptomatic hypocalcemia following a single dose of zoledronic acid in a patient with bone metastases secondary to breast cancer.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Hypocalcemia; Hypophosphatemia; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Vitamin D Deficiency; Zoledronic Acid | 2021 |
Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hypocalcemia; Imidazoles; Multiple Myeloma; Tomography, X-Ray Computed; Vitamin D Deficiency; Zoledronic Acid | 2014 |
Hypocalcaemia in patients with metastatic bone disease treated with denosumab.
Topics: Antineoplastic Agents; Biomarkers; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Clinical Trials, Phase III as Topic; Denosumab; Diphosphonates; Humans; Hypocalcemia; Imidazoles; Incidence; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Vitamin D Deficiency; Zoledronic Acid | 2015 |
Hypocalcemia Secondary to Zoledronate Therapy in a Patient With Low Vitamin D Level.
Topics: Bone Density Conservation Agents; Calcium; Diphosphonates; Humans; Hypocalcemia; Hypoparathyroidism; Imidazoles; Lung Neoplasms; Male; Middle Aged; Risk Factors; Small Cell Lung Carcinoma; Vitamin D Deficiency; Zoledronic Acid | 2015 |
A tale of three diseases of the bone.
Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Calcium Carbonate; Cholecalciferol; Diphosphonates; Female; Humans; Hypocalcemia; Imidazoles; Lumbar Vertebrae; Osteitis Deformans; Osteomalacia; Vitamin D Deficiency; Zoledronic Acid | 2008 |
Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
Topics: Animals; Apoptosis; Diphosphonates; Disease Models, Animal; Femur; Gene Expression Regulation; Humans; Imidazoles; Inflammation; Jaw Diseases; Oligonucleotide Array Sequence Analysis; Osteoclasts; Osteogenesis; Osteonecrosis; Rats; Rats, Sprague-Dawley; Tooth Extraction; Vitamin D; Vitamin D Deficiency; Zoledronic Acid | 2010 |
Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency.
Topics: Bone Neoplasms; Diphosphonates; Humans; Hypocalcemia; Imidazoles; Male; Prostatic Neoplasms; Vitamin D Deficiency; Zoledronic Acid | 2004 |